ATE323886T1 - Verfahren zur diagnose der alzheimerschen krankheit - Google Patents
Verfahren zur diagnose der alzheimerschen krankheitInfo
- Publication number
- ATE323886T1 ATE323886T1 AT02705902T AT02705902T ATE323886T1 AT E323886 T1 ATE323886 T1 AT E323886T1 AT 02705902 T AT02705902 T AT 02705902T AT 02705902 T AT02705902 T AT 02705902T AT E323886 T1 ATE323886 T1 AT E323886T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- diagnosing alzheimer
- glycoproteins
- dementia
- diagnosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
- G01N2333/42—Lectins, e.g. concanavalin, phytohaemagglutinin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26384101P | 2001-01-23 | 2001-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE323886T1 true ATE323886T1 (de) | 2006-05-15 |
Family
ID=23003453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02705902T ATE323886T1 (de) | 2001-01-23 | 2002-01-23 | Verfahren zur diagnose der alzheimerschen krankheit |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20020150878A1 (de) |
| EP (1) | EP1356299B1 (de) |
| AT (1) | ATE323886T1 (de) |
| CA (1) | CA2442708A1 (de) |
| DE (1) | DE60210741D1 (de) |
| WO (1) | WO2002059619A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020033126A (ko) * | 2002-03-08 | 2002-05-04 | 김용선 | 병원성 프리온 단백의 n말단의 비효소적 당화반응 최종산물의 검출에 의한 프리온 질환의 진단 |
| GB0508863D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Peptide |
| CL2007002908A1 (es) | 2007-10-09 | 2008-05-30 | Univ Concepcion | Procedimiento electroquimico in vitro para evaluar capacidad neurotoxica de estructuras, principios activos y/o compuestos de interes en celulas vivas y que comprende medir y cuantificar los parametros electricos en membranas expuestas a dichos agreg |
| ES2889914B2 (es) * | 2020-07-01 | 2022-07-21 | Univ Miguel Hernandez De Elche | PATRON DE GLICOSILACION DE sAPPalfa Y/O sAPPbeta COMO BIOMARCADOR DIAGNOSTICO DE LA ENFERMEDAD DE ALZHEIMER, METODO Y KIT BASADOS EN EL MISMO |
| WO2022042873A1 (en) | 2020-08-27 | 2022-03-03 | Immunologik Gmbh | Pharmaceutically acceptable lectins derived from plants, fungi and bacteria for the treatment of sars-cov-2 infections |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1313496C (en) * | 1988-04-29 | 1993-02-09 | James Wilson Dennis | Diagnostic method to screen tumors |
| AUPO943297A0 (en) * | 1997-09-24 | 1997-10-16 | University Of Melbourne, The | Diagnostic test for alzheimer's disease |
| AU2001259046A1 (en) * | 2000-04-07 | 2001-10-23 | Monash University | Diagnostic test for alzheimer's disease |
-
2002
- 2002-01-17 US US10/051,653 patent/US20020150878A1/en not_active Abandoned
- 2002-01-23 AT AT02705902T patent/ATE323886T1/de not_active IP Right Cessation
- 2002-01-23 CA CA002442708A patent/CA2442708A1/en not_active Abandoned
- 2002-01-23 WO PCT/US2002/001874 patent/WO2002059619A2/en not_active Ceased
- 2002-01-23 EP EP02705902A patent/EP1356299B1/de not_active Expired - Lifetime
- 2002-01-23 DE DE60210741T patent/DE60210741D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002059619A3 (en) | 2002-10-17 |
| EP1356299A2 (de) | 2003-10-29 |
| US20020150878A1 (en) | 2002-10-17 |
| DE60210741D1 (de) | 2006-05-24 |
| WO2002059619A2 (en) | 2002-08-01 |
| CA2442708A1 (en) | 2002-08-01 |
| EP1356299B1 (de) | 2006-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE526041T1 (de) | Verfahren zur hemmung okularer vorgänge | |
| MA29528B1 (fr) | Agents de fixation | |
| IN2014DN05011A (de) | ||
| ATE404118T1 (de) | System für kontinuierliche leistungstests | |
| WO2003071927A3 (en) | Diagnostics and therapeutics for macular degeneration-related disorders | |
| ATE528410T1 (de) | Verfahren und zusammensetzungen zur diagnose von altersbedingter maculadegeneration | |
| CA2420186A1 (en) | Methods for diagnosing a neurodegenerative condition | |
| WO2002010725A3 (en) | Method for non-invasively determining the concentration of an analyte by compensating for the effect of tissue hydration | |
| DE60232522D1 (de) | Verfahren zur vorhersage der behandlungsresultate | |
| WO2006036601A3 (en) | Process control monitors for the fabrication interferometric modulators | |
| WO2000072015A3 (en) | Diagnostics and therapeutics for cardiovascular disorders | |
| CA2374521A1 (en) | Test question response verification system | |
| WO2005042761A3 (en) | Biomarkers for amyotrophic lateral sclerosis | |
| WO2003007803A3 (en) | Methods for diagnosing and treating alzheimer's disease and parkinson's disease | |
| ATE324624T1 (de) | Verfahren zur prozessgesteuerten und kundenindividuellen herstellung eines gegenstandes | |
| AU2003259222A1 (en) | Method of diagnosing alzheimer's disease | |
| DE60210741D1 (de) | Verfahren zur diagnose der alzheimerschen krankheit | |
| HUP0003684A2 (hu) | Alzheimer-kór diagnosztizálására szolgáló vizsgálat | |
| FI20031370A0 (fi) | Automaattinen hemoglobiinin määritysmenetelmä vastasyntyneiden seulontaan | |
| AU2002238766A1 (en) | Diagnostic screens for alzheimer's disease | |
| ATE391954T1 (de) | Verfahren zur steuerung eines ressourcenzugriffs eines prozesses durch einen elternprozess | |
| DE60137513D1 (de) | Methode zur Diagnose von oder zur Bestimmung des Risikos für Psychose beinhaltend die Bestimmung einer heterozygoten Mutation der Methylentetrahydrolfolatreduktase (MTHFR) | |
| WO2001085980A3 (en) | Enzymatic assays for screening anti-cancer agents | |
| DE602004030819D1 (de) | Angiogenesehemmende moleküle und ihre verwendung bei der behandlung und diagnose von krebs | |
| WO2004035597A3 (en) | Methods of assessing the risk of reproductive failure by measuring telomere length |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |